synthetic preimplantation factor
Preimplantation factor (PIF) is a peptide secreted by trophoblast cells prior to placenta formation in early embryonic development. Human embryos begin to express PIF at the 4-cell stage, with expression increasing by the morula stage and continuing to do so throughout the first trimester. Expression of preimplantation factor in the blastocyst was discovered as an early correlate of the viability of the eventual pregnancy. Preimplantation factor was identified in 1994 by a lymphocyte platelet-binding assay, where it was thought to be an early biomarker of pregnancy. It has a simple primary structure with a short sequence of fifteen amino acids without any known quaternary structure. A synthetic analogue of preimplantation factor (commonly abbreviated in studies as sPIF or PIF*) that has an identical amino acid sequence and mimics the normal biological activity of PIF has been developed and is commonly used in research studies, particularly those that aim to study potential adult therapeutics. — Wikipedia
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Earliest trial started Aug 1, 2014 (NCT02239562)
Timeline
Indications
Mechanism of action
- reactive aldehydeINHIBITOR
reactive aldehyde inhibitor
- preimplantation factorSupplementation
preimplantation factor supplementation
Chemistry & pharmacology
SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O- Mol. weight
- 1614.822 g/mol
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPreimplantation factor ↗
- NCATS3K6A6FJ98O ↗
- ChEMBLCHEMBL4298118 ↗
Also known as
- preimplantation factor
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03593421 | Phase 2 | Feb 1, 2019 | BioIncept LLC, University of Miami |
| NCT03593460 | Phase 2 | Nov 1, 2018 | BioIncept LLC, University of Miami |
| NCT00517907 | Phase 1 | Jan 1, 2016 | BioIncept LLC, Hebrew University |
| NCT02239562 | Phase 1 | Aug 1, 2014 | BioIncept LLC, University of Miami |
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioIncept LLC | For profit | 4 | 0 | 2 | 2014 |
| University of Miami | Academic/Hospital | 3 | 3 | 2 | 2014 |
| Hebrew University | Academic/Hospital | 1 | 1 | 1 | 2016 |